What is the therapeutic potential of exosomes?

Project specs

Format

2D/3D

Category

Biology

Contact

Maria Ines Mitrani

Country

USA

Length

01:00

Summary

Organicell™ is a clinical-stage biopharmaceutical company that has developed its lead biologic drug called Zofin™. This drug is an acellular biologic therapeutic manufactured to retain naturally occurring microRNAs. Zofin™ contains over 300 growth factors, cytokines, chemokines, and exosomes derived from perinatal tissues. We believe that the key to Zofin’s™ therapeutic effect is in the intra-exosome cargo. Zofin™ is currently being studied in clinical trials for COVID-19 and other conditions, such as COPD and Osteoarthritis.

Researcher Profile

Based in South Florida, Organicell™ is a publicly traded biotechnology company committed to the research, development and manufacture of new biologic medicine, with a focus on current and potential regenerative therapeutics. Organicell™ is the leading, fully integrated Biologic Medicine Company. Our mission is to transform regenerative medicine through the development of novel nano-technologies and to become the health care incubator for the next generation of biologic medicines.

What if cells don’t divide correctly? The role of…

Bellvitge Institute for Biomedical Research (IDIBELL) aims to characterize the…